Latest News about Psychedelics
Recent news which mentions Psychedelics
Norwalk, CT's First Cannabis Dispensary Faces Solar Panel Dilemma: Tree Shade And Low ROI Hinder Compliance
September 16, 2024
Tickers
NEWS
From Benzinga
Psychedelic Biotech Psyence Grows Pipeline With Trials And Psilocybin Drug Developer Acquisition
September 16, 2024
From Benzinga
Nebraska Medical Cannabis Legalization Heads Into November Election Amid Signature Controversy
September 16, 2024
Tickers
NEWS
From Benzinga
Marijuana Sales Hit Record Highs In These 6 US States: Is Marijuana Outpacing Alcohol?
September 13, 2024
Tickers
NEWS
From Benzinga
Magic Mushrooms Boosted Humanity's Evolutionary Success, New Study Says: Did Psilocybin Make Early Humans Better Hunters?
September 13, 2024
From Benzinga
MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward?
September 12, 2024
From Benzinga
LSD, MDMA And d-Amphetamine: Study Provides New Insights Into Neurobiological Effects
September 12, 2024
From Benzinga
Multidisciplinary Association For Psychedelic Studies Eyes State-Level Legalization After FDA Denial Of MDMA Therapy
September 11, 2024
From Benzinga
PharmAla Biotech Partners With Johns Hopkins University For MDMA Clinical Trials, Terminates Red Light Holland Contract
September 11, 2024
From Benzinga
Biden Administration Finalizes Rule To Expand Mental Health Care Access: How This Could Impact The Psychedelics Industry
September 10, 2024
Tickers
NEWS
From Benzinga
Incannex Secures $60M Financing To Drive Advances In Psychedelic And Cannabinoid Therapies
September 10, 2024
Tickers
IXHL
From Benzinga
UK Government Drug Ban Targets 'Zombie Drug' Xylazine And Other Opioids
September 10, 2024
From Benzinga
Moxy: The Short, Intense Psychedelic High Sweeping The Globe
September 10, 2024
From Benzinga
Psyence Biomed Launches First Trial Site In Australia For Phase IIb Psilocybin Study In Palliative Care
September 09, 2024
From Benzinga
Cannabis Use Rose Among US Adults Over 10 Years, But Kept Steady In Teens, Finds New Study
September 09, 2024
Tickers
NEWS
From Benzinga
Psilocybin Drug By Psilera Could Treat Frontotemporal Dementia Without Psychoactive Effects
September 09, 2024
Tickers
NEWS
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.